banner add

F.D.A. Expands Access to Clozapine, a Key Treatment for Schizophrenia

Federal regulators will no longer require patients to provide blood tests before receiving the drug from pharmacies.

from NYT > Health https://ift.tt/4vun7kd
via IFTTT

No comments

Employer Health Costs Are Expected to Spike in 2027

A new U.S. survey anticipates an average increase of 11 percent unless benefits are cut, the highest rate in decades. Other findings also pr...

Theme images by PLAINVIEW. Powered by Blogger.